DigiPath Inks Deal with First Medical Marijuana Dispensary in Las Vegas, Euphoria Wellness

LAS VEGAS, May 28, 2015 /PRNewswire/  DigiPath Labs of Las Vegas, a subsidiary of DigiPath, Inc. (OTCBB and OTCQB: DIGPD), has entered into a one-year agreement with Euphoria Wellness to conduct comprehensive safety and potency tests on the products Euphoria will sell in its Las Vegas medical marijuana dispensary. Euphoria Wellness, expected to be the first cannabis dispensary to open in Las Vegas, chose to partner with DigiPath Labs as part of its strategy to set the highest medical marijuana patient safety and education standards in the industry. DigiPath Labs will analyze samples of products sold by Euphoria Wellness for unsafe levels of contaminants such as heavy metals, microbes, mycotoxins, pesticides, and solvents, which can exacerbate patient health issues, says Todd Denkin, president of DigiPath Labs. We will also quantify cannabinoid and terpenoid levels and deliver detailed reports that Euphoria s staff can use to help patients. Comprehensive cannabis potency te
http://bit.ly/1QcKJTI

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: